SCHEMBL6898581

SCHEMBL6898581

C=C(C(C)=O)C(=O)OCCOC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
TSHR P16473 4/20 0.46
THRB P10828 1/20 0.45
CHRM5 P08912 2/20 0.45
CHRM1 P11229 2/20 0.45
CHRM3 P20309 2/20 0.45
PGR P06401 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
HTR1A P08908 1/20 0.41
CHRNB2 P17787 1/20 0.41
TBXA2R P21731 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA7 P36544 1/20 0.41
CHRNA4 P43681 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CHRNA10 Q9GZZ6 1/20 0.41
CHRNA9 Q9UGM1 1/20 0.41
GALR3 O60755 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21693942 0.91 ALDH1A1 (0.50) ALDH1A1TSHRTHRBCHRM5CHRM1
SCHEMBL10944510 0.91 TSHR (0.50) ALDH1A1TSHRTHRBCHRM5CHRM1
SCHEMBL15078188 0.86 THRB (0.61) ALDH1A1TSHRTHRBCHRM5CHRM1
SCHEMBL14934926 0.84 THRB (0.44) ALDH1A1TSHRTHRBCHRM5CHRM1
SCHEMBL5408195 0.82 TSHR (0.48) ALDH1A1TSHRTHRBCHRM1SMN1; SMN2
SCHEMBL14631623 0.82 TSHR (0.41) ALDH1A1TSHRTHRBCHRM5CHRM1
SCHEMBL28286104 0.82 ALDH1A1 (0.39) ALDH1A1TSHRTHRBCHRM5CHRM1
SCHEMBL303014 0.81 THRB (0.65) ALDH1A1TSHRTHRBCHRM5CHRM1
SCHEMBL19620350 0.81 THRB (0.46) ALDH1A1TSHRTHRBCHRM5CHRM1
SCHEMBL5408269 0.81 THRB (0.71) ALDH1A1TSHRTHRBSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597477-B2 Finely divided aqueous emulsion polymers and use thereof for hydrophobic coatings BASF SE (DE) 2020-03-24 US claimed
WO-2017012691-A1 REDISPERSIBLE POLYMER POWDER COMPOSITIONS WITH IMPROVED IMPACT RESISTANCE ORGANIK KIMYA SANAYI VE TIC. A.S. (TR) 2017-01-26 WO claimed
WO-1995001381-A1 POLYMER BLENDS COMPRISING SULFONATE GROUP-CONTAINING SURFACTANTS EASTMAN CHEMICAL COMPANY (US) 1995-01-12 WO claimed
WO-1995001382-A1 POLYMER BLENDS GIVING HIGH GLOSS EASTMAN CHEMICAL COMPANY (US) 1995-01-12 WO claimed
EP-0558612-A1 POLYMER BLENDS FOR AQUEOUS DISPERSIONS HAVING IMPROVED FREEZE-THAW STABILITY. EASTMAN KODAK CO (US) 1993-09-08 EP claimed
WO-1992009657-A1 POLYMER BLENDS FOR AQUEOUS DISPERSIONS HAVING IMPROVED FREEZE-THAW STABILITY EASTMAN KODAK COMPANY (US) 1992-06-11 WO claimed
US-20240209173-A1 PROCESS FOR PREPARING COATED SHAPED BODIES AND THEIR USE BASF SE (DE) 2024-06-27 US disclosed
CN-117794879-A Dry mixtures of building materials comprising solid vinyl ester resins 瓦克化学股份公司 2024-03-29 CN disclosed
EP-4326804-A1 PROCESS FOR PREPARING COATED SHAPED BODIES AND THEIR USE BASF SE (DE) 2024-02-28 EP disclosed
US-20230383043-A1 PROCESS OF PRODUCING POLYMER DISPERSIONS BASF SE (DE) 2023-11-30 US disclosed
EP-3847219-A1 MODIFIED LATENT CROSSLINKER IN POLYMERIC SYSTEMS SWIMC LLC (US) 2021-07-14 EP disclosed
US-10676634-B2 Modified latent crosslinker in polymeric systems SWIMC LLC (US) 2020-06-09 US disclosed
US-20200071559-A1 MODIFIED LATENT CROSSLINKER IN POLYMERIC SYSTEMS THE SHERWIN-WILLIAMS COMPANY (US) 2020-03-05 US disclosed
US-9527795-B2 Methylene beta-ketoester monomers, methods for making methylene beta-ketoester monomers, polymerizable compositions and products formed therefrom SIRRUS, INC. (US) 2016-12-27 US disclosed
US-20140288230-A1 METHYLENE BETA-KETOESTER MONOMERS, METHODS FOR MAKING METHYLENE BETA-KETOESTER MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM SIRRUS, INC. 2014-09-25 US disclosed
US-20140288230-A1 METHYLENE BETA-KETOESTER MONOMERS, METHODS FOR MAKING METHYLENE BETA-KETOESTER MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM SIRRUS, INC. 2014-09-25 US disclosed
EP-1473331-B1 ANTIFOULING WATER-BASED COATING COMPOSITION ASAHI KASEI CHEMICALS CORP (JP) 2013-10-30 EP disclosed
WO-2013066629-A1 METHYLENE BETA-KETOESTER MONOMERS, METHODS FOR MAKING METHYLENE BETA-KETOESTER MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM BIOFORMIX, LLC (US) 2013-05-10 WO disclosed
EP-1473331-A1 ANTIFOULING WATER-BASED COATING COMPOSITION Asahi Kasei Kabushiki Kaisha (JP) 2004-11-03 EP disclosed
US-6218468-B1 CARRIED OUT IN THE PRESENCE OF FROZEN MICELLES OF AMPHIPHILIC SUBSTANCES. BASF AKTIENGESELLSCHAFT (DE) 2001-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288230-A1 METHYLENE BETA-KETOESTER MONOMERS, METHODS FOR MAKING METHYLENE BETA-KETOESTER MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM MACF1, MSMO1, ILK ALDH1A1 1292/4885TSHR 4869/4885THRB 4077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.